| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Canada | 2 | |
| #4 | Israel | 2 | |
| #5 | Republic of Korea | 2 | |
| #6 | Singapore | 2 | |
| #7 | Australia | 1 | |
| #8 | EPO (European Patent Office) | 1 | |
| #9 | Mexico | 1 | |
| #10 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Animal care | |
| #5 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chen Shuhui | 11 |
| #2 | Chen Kevin X | 6 |
| #3 | Zhou Kai | 6 |
| #4 | Hu Boyu | 6 |
| #5 | Guo Qiang | 5 |
| #6 | Wei Changqing | 5 |
| #7 | Xiao Minliang | 5 |
| #8 | Xiao Yao | 5 |
| #9 | Wu Hao | 4 |
| #10 | Liao Yonggang | 4 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020192762A1 | Salt form and crystal form of a2a receptor antagonist and preparation method therefor | |
| WO2020125747A1 | Crystal form and amorphous form of mek inhibitor and applications thereof | |
| WO2020007329A1 | Polymorph of hdac6-selective inhibitor and application thereof | |
| CN111868032A | Kynurenine pathway inhibitors | |
| CN107840887A | A kind of new monoclonal antibodies of PD 1 |